Lonza Signs Development and Manufacturing Agreement with Genmab

06:10 AM | October 25, 2011 | Deepti Ramesh

Lonza says it has signed a development and manufacturing agreement with biotechnology company Genmab (Copenhagen, Denmark) for a novel antibody drug conjugate (ADC), HuMax-TF. This agreement secures a...